The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.
Trump
Administration
Supported by
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.
By Rebecca RobbinsChristina Jewett and Dani Blum
The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information…
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over…
US president has said that he will use tariffs to bring down costly medical drugs, but the impact remains uncertain.
The order to place cannabis in the same category as Tylenol with codeine would mark the most significant change in US drug policy…
The Addiction Science Defense Network released a report saying federal actions have potentially destroyed 50 years of research.
President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their…
